ArticleTurkish journal of physical medicine and rehabilitation2025
The impact of obesity on the outcomes of complex decongestive therapy among patients with breast cancer-related lymphedema.
Article in Turkish journal of physical medicine and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictors of response to compression therapy in breast cancer-related lymphoedema: a systematic review and meta-analysis.EClinicalMedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aims to evaluate the influence of complex decongestive therapy (CDT) on patients with breast cancer-related lymphedema (BCRL) in terms of reducing volume, improving functional capabilities, and enhancing the quality of life and analyze the effect of obesity on their recovery process. Patients and methods: This retrospective study was conducted between January 2018 and March 2020. The investigation comprised individuals with unilateral BCRL who received CDT during the previous year. The participants were split into two classifications: those with a normal or overweight status (Group 1) and those classified as obese or morbidly obese (Group 2). Each participant engaged in CDT sessions five times weekly for three weeks. The groups were compared regarding their functional status and quality of life scores as measured by the Quick Disabilities of the Arm, Shoulder, and Hand and Lymphedema Quality of Life (LYMQOL)-Arm questionnaires. Results: This study included 81 female patients (mean age: 53.6±10.4 years; range, 28 to 87 years) with BCRL. Half of the participants were identified as obese and the mean body mass index (BMI) was 30.32±4.63 kg/m Conclusion: The influence of CDT on decreasing volume and improving functionality was comparable between obese and nonobese patients with BCRL; however, obesity may negatively impact CDT outcomes concerning quality of life issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.